整合人工智能病灶分类、年龄与BI-RADS评估以减少乳腺超声良性活检
本回顾性研究纳入两家医院筛查乳腺超声中BI-RADS 3至5类肿块的无症状女性,开发并验证整合AI双平面分类、年龄与BI-RADS的活检回避策略。外部验证队列中该策略将特异度从53.3%提高至80.7%而保持敏感度100%,可避免61.7%的BI-RADS 4a类良性活检。
要点
- BI-RADS 4a类肿块若AI双平面均判为良性,或年龄≤45岁且AI判为良性与恶性,可降级为BI-RADS 3类。
- 外部验证队列中该策略避免61.7%(37/60)的BI-RADS 4a类良性活检。
- 特异度由53.3%升至80.7%,敏感度维持100%(31/31)。
核心结论
- 整合AI双正交平面分类、年龄与BI-RADS分类的策略提高了筛查乳腺超声的特异度,同时保持非劣效的敏感度。
研究设计与样本
- 回顾性研究,开发队列393名女性(中位年龄45岁,IQR 40-50岁)含101例恶性,外部验证队列166名女性(中位年龄47岁,IQR 42-51岁)含31例恶性,来自两家医院2019年12月至2020年12月及2020年6月至2020年12月的筛查乳腺超声。
诊断标准与关键数值
- 外部验证队列中,策略将特异度从53.3%(72/135;95% CI:45.0, 62.1)提高至80.7%(109/135;95% CI:74.2, 87.5;p < 0.001),敏感度均为100%(31/31;95% CI:98.9, 100),并避免61.7%(37/60;95% CI:48.2, 73.7)的BI-RADS 4a类良性活检。
临床应用与阅片要点
- 作者提出的策略为:BI-RADS 4a类肿块若AI分类在所有女性中均为「双平面良性」,或在≤45岁女性中为「良性与恶性」,则降级为BI-RADS 3类。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To develop and test AI-integrated biopsy avoidance strategies to improve the specificity of screening breast ultrasound (US).
MATERIALS AND METHODS: This retrospective study included consecutive asymptomatic women with BI-RADS 3, 4a, 4b, 4c, or 5 masses on screening breast US exams acquired from two hospitals between December 2019 and December 2020 (development cohort) and June 2020 and December 2020 (external validation cohort). If more than one lesion was present, the most suspicious lesion was analyzed. Logistic regression was used to develop the AI-integrated biopsy avoidance strategies in which BI-RADS 4a masses were downgraded to BI-RADS 3 if the AI classifications were "both planes benign" in all women or "benign and malignant" in the women ≤ 45 years of age. Diagnostic performance metrics were calculated for both cohorts and compared to initial assessments by radiologists using the Wilcoxon rank-sum test for noninferiority of sensitivity (relative noninferiority margin, 5%) and the McNemar test for specificity.
RESULTS: The development and external validation cohorts consisted of 393 women (median age, 45 years [IQR, 40-50 years]) with 101 malignancies and 166 women (median age, 47 years [IQR, 42-51 years]) with 31 malignancies, respectively. The developed strategy improved specificity from 53.3% (72/135; 95% CI: 45.0, 62.1) to 80.7% (109/135; [95% CI: 74.2, 87.5]; p < 0.001) while maintaining sensitivity (both 100% [31/31; 95% CI: 98.9, 100]), and would have avoided 61.7% (37/60 [95% CI: 48.2, 73.7]) of benign biopsies of BI-RADS 4a masses in the external validation cohort.
CONCLUSION: A strategy integrating AI classification in two orthogonal planes, age, and BI-RADS classification improved the specificity of screening breast US while maintaining non-inferior sensitivity.
KEY POINTS: Question How can integrating AI lesion classification, age, and BI-RADS assessment effectively reduce benign biopsies in screening breast ultrasound? Findings A strategy integrating AI classifications, age, and BI-RADS using multivariable logistic regression improved specificity while maintaining non-inferior sensitivity in breast ultrasound screening. Clinical relevance The integration of AI classification in two orthogonal planes, along with patient age and BI-RADS classification, shows potential for reducing benign breast biopsies without compromising sensitivity, leading to more efficient clinical decision-making, reduced patient anxiety, and decreased healthcare resource utilization.
引用
- Ju Y, Zhang G, Wan Y, et al. Integration of AI lesion classification, age, and BI-RADS assessment to reduce benign biopsies on breast ultrasound. Eur Radiol. 2025. PMID: 40121344. doi:10.1007/s00330-025-11467-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。